218 related articles for article (PubMed ID: 9345104)
1. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
Bignell GR; Canzian F; Shayeghi M; Stark M; Shugart YY; Biggs P; Mangion J; Hamoudi R; Rosenblatt J; Buu P; Sun S; Stoffer SS; Goldgar DE; Romeo G; Houlston RS; Narod SA; Stratton MR; Foulkes WD
Am J Hum Genet; 1997 Nov; 61(5):1123-30. PubMed ID: 9345104
[TBL] [Abstract][Full Text] [Related]
2. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium.
Lesueur F; Stark M; Tocco T; Ayadi H; Delisle MJ; Goldgar DE; Schlumberger M; Romeo G; Canzian F
J Clin Endocrinol Metab; 1999 Jun; 84(6):2157-62. PubMed ID: 10372725
[TBL] [Abstract][Full Text] [Related]
3. Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na+/I- symporter.
Neumann S; Willgerodt H; Ackermann F; Reske A; Jung M; Reis A; Paschke R
J Clin Endocrinol Metab; 1999 Oct; 84(10):3750-6. PubMed ID: 10523025
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1.
Bevan S; Pal T; Greenberg CR; Green H; Wixey J; Bignell G; Narod SA; Foulkes WD; Stratton MR; Houlston RS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3701-4. PubMed ID: 11502798
[TBL] [Abstract][Full Text] [Related]
5. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.
McKay JD; Lesueur F; Jonard L; Pastore A; Williamson J; Hoffman L; Burgess J; Duffield A; Papotti M; Stark M; Sobol H; Maes B; Murat A; Kääriäinen H; Bertholon-Grégoire M; Zini M; Rossing MA; Toubert ME; Bonichon F; Cavarec M; Bernard AM; Boneu A; Leprat F; Haas O; Lasset C; Schlumberger M; Canzian F; Goldgar DE; Romeo G
Am J Hum Genet; 2001 Aug; 69(2):440-6. PubMed ID: 11438887
[TBL] [Abstract][Full Text] [Related]
6. Linkage analysis of candidate genes in autoimmune thyroid disease. III. Detailed analysis of chromosome 14 localizes Graves' disease-1 (GD-1) close to multinodular goiter-1 (MNG-1). International Consortium for the Genetics of Autoimmune Thyroid Disease.
Tomer Y; Barbesino G; Greenberg DA; Concepcion E; Davies TF
J Clin Endocrinol Metab; 1998 Dec; 83(12):4321-7. PubMed ID: 9851771
[TBL] [Abstract][Full Text] [Related]
7. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D
Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827
[TBL] [Abstract][Full Text] [Related]
8. Mapping a dominant form of multinodular goiter to chromosome Xp22.
Capon F; Tacconelli A; Giardina E; Sciacchitano S; Bruno R; Tassi V; Trischitta V; Filetti S; Dallapiccola B; Novelli G
Am J Hum Genet; 2000 Oct; 67(4):1004-7. PubMed ID: 10986044
[TBL] [Abstract][Full Text] [Related]
9. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
10. Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene.
Kraimps JL; Canzian F; Jost C; Menet E; Amati P; Levillian P; Harach R; Lesueur F; Barbier J; Romeo G; Bonneau D
Surgery; 1999 Dec; 126(6):1188-94. PubMed ID: 10598206
[TBL] [Abstract][Full Text] [Related]
11. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis.
Cavaco BM; Batista PF; Sobrinho LG; Leite V
J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515
[TBL] [Abstract][Full Text] [Related]
12. A new locus for a dominant form of multinodular goiter on 3q26.1-q26.3.
Takahashi T; Nozaki J; Komatsu M; Wada Y; Utsunomiya M; Inoue K; Takada G; Koizumi A
Biochem Biophys Res Commun; 2001 Jun; 284(3):650-4. PubMed ID: 11396950
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter.
Bayer Y; Neumann S; Meyer B; Rüschendorf F; Reske A; Brix T; Hegedüs L; Langer P; Nürnberg P; Paschke R
J Clin Endocrinol Metab; 2004 Aug; 89(8):4044-52. PubMed ID: 15292347
[TBL] [Abstract][Full Text] [Related]
14. Further indications for genetic heterogeneity of euthyroid familial goiter.
Neumann S; Bayer Y; Reske A; Tajtáková M; Langer P; Paschke R
J Mol Med (Berl); 2003 Nov; 81(11):736-45. PubMed ID: 14564411
[TBL] [Abstract][Full Text] [Related]
15. At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family.
McKay JD; Williamson J; Lesueur F; Stark M; Duffield A; Canzian F; Romeo G; Hoffman L
Eur J Endocrinol; 1999 Aug; 141(2):122-5. PubMed ID: 10427154
[TBL] [Abstract][Full Text] [Related]
16. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
[TBL] [Abstract][Full Text] [Related]
17. [Progress in the molecular genetic research of multinodular goiter].
Zhang R; Du L; Peng Z; Chu J; Liu X; Tao S; Luo Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Oct; 17(5):359-61. PubMed ID: 11024220
[TBL] [Abstract][Full Text] [Related]
18. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
19. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
[TBL] [Abstract][Full Text] [Related]
20. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.
Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V
Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
